CIK: 0001012622 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value ($000): $532,644 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | QUIDEL CORP | 1,756,988 | $131,827 | 24.7% | $25223.83 | — | COM | 74838J101 |
| — | AMARIN CORP PLC | 5,226,005 | $112,046 | 21.0% | $582.46 | — | SPONS ADR NEW | 023111206 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,923,290 | $104,704 | 19.7% | $47.23 | — | COM | G11196105 |
| — | ACCELERATE DIAGNOSTICS INC | 4,213,152 | $71,202 | 13.4% | $22.26 | — | COM | 00430H102 |
| — | DERMIRA INC | 2,528,311 | $38,329 | 7.2% | $13.16 | — | COM | 24983L104 |
| — | SOLENO THERAPEUTICS INC | 3,870,627 | $11,380 | 2.1% | $1.78 | — | COM NEW | 834203200 |
| — | AGENUS INC | 2,772,103 | $11,282 | 2.1% | $2.95 | — | COM NEW | 00847G705 |
| — | MOTUS GI HLDGS INC | 3,806,666 | $8,717 | 1.6% | $3.08 | — | COM | 62014P108 |
| — | VERMILLION INC | 9,825,289 | $7,958 | 1.5% | $1445.80 | — | COM NEW | 92407M206 |
| — | AMARIN CORP PLC | 1,959,600 | $7,657 | 1.4% | $582.46 | — | Call | 023111206 |
| OPK | OPKO HEALTH INC | 4,373,076 | $6,428 | 1.2% | $5.37 | -68.8% | COM | 68375N103 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,110,666 | $5,709 | 1.1% | $4.84 | +5.1% | COM | 69404D108 |
| — | ANTARES PHARMA INC | 688,237 | $3,235 | 0.6% | $4.13 | — | COM | 036642106 |
| — | QUIDEL CORP | 247,700 | $3,111 | 0.6% | $25223.83 | — | Call | 74838J101 |
| — | BIOLASE INC | 5,173,250 | $2,859 | 0.5% | $1.21 | — | COM NEW | 090911207 |
| COR | AMERISOURCEBERGEN CORP | 25,000 | $2,126 | 0.4% | $71.20 | 0.0% | COM | 03073E105 |
| — | ACCELERATE DIAGNOSTICS INC | 483,500 | $1,502 | 0.3% | $22.26 | — | Call | 00430H102 |
| BIIB | BIOGEN INC | 4,868 | $1,444 | 0.3% | $213.68 | +29.8% | COM | 09062X103 |
| — | CONTRAFECT CORP | 1,502,766 | $933 | 0.2% | $2.06 | — | COM | 212326102 |
| DB | DEUTSCHE BANK AG | 25,000 | $195 | 0.0% | $6.73 | 0.0% | NAMEN AKT | D18190898 |